Atea Pharmaceuticals, Inc. (AVIR)
USD 3.16
(0.0%)
USD 3.16
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 351.36 Million | 48.63 Million | - | - |
| Cost of Revenue | 70.09 Million | 260 Thousand | 29 Thousand | 19 Thousand | 17 Thousand | 17 Thousand |
| Gross Profit | -70.09 Million | -260 Thousand | 351.33 Million | 48.61 Million | -17 Thousand | -17 Thousand |
| Operating Expenses | 94.07 Million | 130.65 Million | 212.99 Million | 59.66 Million | 14.6 Million | 9.47 Million |
| Selling, General and Administrative Expenses | 49.91 Million | 48.71 Million | 45.78 Million | 21.64 Million | 4.43 Million | 2.8 Million |
| Research and Development Expenses | 132.84 Million | 81.93 Million | 167.2 Million | 38.02 Million | 10.17 Million | 6.67 Million |
| Other Expenses | -88.69 Million | - | - | - | - | - |
| Cost and Expenses | 164.16 Million | 130.65 Million | 212.99 Million | 59.66 Million | 14.6 Million | 9.47 Million |
| Operating Income | -164.16 Million | -130.65 Million | 138.37 Million | -11.03 Million | -14.6 Million | -9.47 Million |
| Interest Expense | - | 11.15 Million | - | - | - | - |
| Income Tax Expense | 1.01 Million | -3.59 Million | 17.4 Million | -83 Thousand | -574 Thousand | 413 Thousand |
| Earnings before Tax | -134.93 Million | -119.49 Million | 138.59 Million | -10.94 Million | -14.03 Million | -9.06 Million |
| Net Income | -135.95 Million | -115.9 Million | 121.19 Million | -10.86 Million | -13.46 Million | -9.06 Million |
| Earnings Per Share Basic | -1.63 | -1.39 | 1.46 | -0.13 | -0.16 | -0.19 |
| Earnings Per Share Diluted | -1.63 | -1.39 | 1.37 | -0.13 | -0.16 | -0.19 |
| Weighted Average Shares Outstanding | 83.38 Million | 83.24 Million | 82.82 Million | 82.43 Million | 82.61 Million | 47.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 83.38 Million | 83.24 Million | 88.24 Million | 82.43 Million | 82.61 Million | 47.29 Million |
| Gross Margin | - | - | 1.00 | 1.00 | - | - |
| EBIT Margin | - | - | 0.39 | -0.23 | - | - |
| Profit Margin | - | - | 0.34 | -0.22 | - | - |
| EBITDA | -119.59 Million | -110.84 Million | 138.4 Million | -11.01 Million | -14.59 Million | -9.46 Million |
| Earnings Before Tax Margin | - | - | 0.39 | -0.23 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 104 Thousand | 104 Thousand | 104 Thousand | 416 Thousand | 104 Thousand | 104 Thousand |
| Gross Profit | -104 Thousand | -104 Thousand | -104 Thousand | -416 Thousand | -104 Thousand | -104 Thousand |
| Operating Expenses | 46.81 Million | 69.7 Million | 46.46 Million | 163.74 Million | 40.78 Million | 35.23 Million |
| Selling, General and Administrative Expenses | 12.11 Million | 12.12 Million | 11.42 Million | - | 12.6 Million | 13.17 Million |
| Research and Development Expenses | 34.69 Million | 57.57 Million | 35.04 Million | - | 28.18 Million | 22.06 Million |
| Other Expenses | -23.2 Million | - | - | - | - | - |
| Cost and Expenses | 46.91 Million | 69.8 Million | 46.57 Million | 164.16 Million | 40.78 Million | 35.23 Million |
| Operating Income | -46.91 Million | -69.8 Million | -46.57 Million | -164.16 Million | -40.78 Million | -35.23 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 243 Thousand | 231 Thousand | 349 Thousand | 1.01 Million | 221 Thousand | 251 Thousand |
| Earnings before Tax | -40.27 Million | -62.93 Million | -38.81 Million | -134.93 Million | -32.92 Million | -27.93 Million |
| Net Income | -40.52 Million | -63.16 Million | -39.16 Million | -135.95 Million | -33.14 Million | -28.18 Million |
| Earnings Per Share Basic | -0.48 | -0.75 | -0.47 | - | -0.40 | -0.34 |
| Earnings Per Share Diluted | -0.48 | -0.75 | -0.47 | - | -0.40 | -0.34 |
| Weighted Average Shares Outstanding | 84.25 Million | 83.91 Million | 83.43 Million | 83.38 Million | 83.39 Million | 83.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.25 Million | 83.91 Million | 83.43 Million | 83.38 Million | 83.39 Million | 83.39 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -46.81 Million | -69.7 Million | -46.46 Million | - | -40.68 Million | -35.13 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
LUG
FEC
GMG
JBNK
0667
ROP